Valuation: LanZhou Foci Pharmaceutical Co.,Ltd.

Market Cap 3.66B 538M 470M 432M 403M 764M 51.24B 776M 5.2B 2.02B 25.13B 2.02B 1.98B 86.61B P/E 2024
65.6x
P/E 2025 89.6x
Enterprise Value 3.18B 468M 409M 375M 350M 664M 44.53B 675M 4.52B 1.75B 21.84B 1.76B 1.72B 75.26B EV / Sales 2024
3.66x
EV / Sales 2025 4.3x
Free-Float
33.21%
Yield 2024
0.16%
Yield 2025 0.23%
1 day+1.56%
1 week-0.69%
Current month+5.14%
1 month-7.61%
3 months-19.73%
6 months-17.13%
Current year-17.13%
1 week 6.63
Extreme 6.63
7.25
1 month 6.63
Extreme 6.63
7.73
Current year 6.63
Extreme 6.63
11.02
1 year 6.63
Extreme 6.63
11.85
3 years 5.84
Extreme 5.84
12.19
5 years 5.84
Extreme 5.84
15.17
10 years 5.84
Extreme 5.84
15.17
Manager TitleAgeSince
Chief Executive Officer 62 2022-04-05
Director of Finance/CFO - 2022-12-01
Corporate Officer/Principal 52 2018-01-31
Director TitleAgeSince
Director/Board Member 71 2022-05-11
Director/Board Member 56 2020-01-01
Chairman 60 2014-05-07
Change 5-day change 1-year change 3-year change Capi.($)
+1.56%-0.69%-13.84%-41.31% 538M
+1.65%+3.41%-12.27%-7.09% 12.81B
+0.13%+1.75%-35.08%-59.56% 4.7B
+2.30%+7.71%-7.97%-11.88% 4.45B
+0.65%+1.44%+8.96%-39.86% 3.8B
+2.01%+5.82%+16.27%-12.90% 3.84B
-0.09%-12.55%-13.92%-22.73% 3.04B
+1.18%+1.33%-12.08%-5.17% 3.03B
+0.80%+1.27%-7.04%-26.27% 2.36B
+3.25%+6.45%-10.89%+28.39% 1.71B
Average +1.34%+3.78%-8.79%-19.84% 4.03B
Weighted average by Cap. +1.33%+4.09%-9.50%-18.50%

Financials

2024 2025
Net sales 980M 144M 126M 116M 108M 205M 13.74B 208M 1.39B 540M 6.74B 542M 530M 23.22B 916M 135M 118M 108M 101M 191M 12.83B 194M 1.3B 505M 6.29B 506M 495M 21.69B
Net income 60.07M 8.84M 7.73M 7.1M 6.62M 12.54M 842M 12.76M 85.44M 33.11M 413M 33.21M 32.48M 1.42B 49.21M 7.24M 6.33M 5.81M 5.42M 10.28M 690M 10.45M 69.99M 27.12M 338M 27.2M 26.61M 1.17B
Net Debt -357M -52.57M -45.94M -42.18M -39.34M -74.58M -5B -75.84M -508M -197M -2.45B -197M -193M -8.46B -479M -70.52M -61.62M -56.58M -52.77M -100M -6.71B -102M -681M -264M -3.29B -265M -259M -11.35B
Logo LanZhou Foci Pharmaceutical Co.,Ltd.
Lanzhou Foci Pharmaceutical Co Ltd is a China-based company mainly engaged in the manufacture of traditional Chinese medicine. The Company's main businesses include the research and development, production and sales of Chinese patent medicines and health products, cultivation and sales of Chinese medicinal materials, processing and sales of Chinese herbal medicines, production and sales of medical devices such as protective masks, and others. The Company's products include Fufang Huangqi Jianpi Oral Liquid, Liuwei Dihuang Pills, Xiaoyao Pills, Xiangsha Yangwei Pills, Shenrong Guben Huanshao Pills, donkey-hide gelatin, Chinese herbal medicine slices, and others. The Company's products cover categories and fields such as tonic, cold, gastrointestinal, gynecology, and tranquilizing sleep.
Employees
1,332
Date Price Change Volume
26-07-02 CN¥7.160 +1.56% 4,391,350
26-07-01 CN¥7.050 +3.52% 6,086,950
26-06-30 CN¥6.810 -5.15% 9,294,400
26-06-29 CN¥7.180 +2.13% 4,312,800
26-06-26 CN¥7.030 -2.50% 3,517,400
  1. Stock Market
  2. Stocks
  3. 002644 Stock